Literature DB >> 2056036

Comparison between methods for serotyping of Candida albicans produces discrepancies in results.

D L Brawner1.   

Abstract

Serotyping of 101 clinical isolates of Candida albicans was done with two sets of Hasenclever original anti-Candida typing sera (HSN 1 and 2) and Iatron Candida Check factor 6 typing serum (IF6). The results of these two methods were compared with slide agglutination reactions of yeast with monoclonal antibody H9. Agglutination reactions with this antibody have been previously shown to correlate with serotype. Results indicate the following correlations: between HSN 1 and HSN 2 serotyping, 93% (kappa = 0.85; 95% confidence interval [CI], 0.70 to 0.99); between IF6 and HSN 1, 60% (kappa = 0.39, 95% CI, 0.19 to 0.58); and between IF6 and HSN 2, 74% (kappa = 0.77; 95% CI, 0.64 to 0.90). Results with HSN 1 and 2 antisera correlated with H9 reactivity at 85 and 89% (kappa = 0.88; 95% CI, 0.75 to 1.00; and kappa = 0.85; CI, 0.70 to 0.99, respectively), while agreement between IF6 and H9 reactivities was less than or equal to 64% (kappa less than or equal to 0.43; 95% CI, 0.14 to 0.60). Autoagglutination of yeast during IF6 serotyping occurred with 21 of the 101 (20.8%) yeast strains. In every case, these yeast strains were serotyped by the HSN methods without autoagglutination and were uniformly type B. This study implies that it may not be possible to make valid comparisons between studies which compare serotype prevalence unless the same methods are used to serotype the yeast. The practicality and utility of serotyping in epidemiological studies are discussed, as are some of the problems associated with the available methods.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056036      PMCID: PMC269927          DOI: 10.1128/jcm.29.5.1020-1025.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Cell surface and intracellular expression of two Candida albicans antigens during in vitro and in vivo growth.

Authors:  D L Brawner; J E Cutler
Journal:  Microb Pathog       Date:  1987-04       Impact factor: 3.738

3.  Biotyping of Candida albicans: results of an international collaborative survey.

Authors:  F C Odds; P Auger; P Krogh; A N Neely; E Segal
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.

Authors:  H C Korting; M Ollert; A Georgii; M Fröschl
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

5.  Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans.

Authors:  B W Hazen; K C Hazen
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Characteristics of Candida albicans adherence to mouse tissues.

Authors:  J E Cutler; D L Brawner; K C Hazen; M A Jutila
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Isolation and characterization of cell surface mutants of Candida albicans.

Authors:  W L Whelan; J M Delga; E Wadsworth; T J Walsh; K J Kwon-Chung; R Calderone; P N Lipke
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype.

Authors:  D A Stevens; F C Odds; S Scherer
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

10.  Isoenzyme biotypes of Candida species.

Authors:  P F Lehmann; B J Kemker; C B Hsiao; S Dev
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

View more
  8 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Candida albicans serotype analysis by flow cytometry.

Authors:  S Mercure; S Sénéchal; P Auger; G Lemay; S Montplaisir
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Evaluation of bichro-latex albicans, a new method for rapid identification of Candida albicans.

Authors:  G Quindos; R San Millan; R Robert; C Bernard; J Ponton
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Epidemiological analysis of Candida albicans strains by multilocus enzyme electrophoresis.

Authors:  D A Caugant; P Sandven
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Serotype prevalence of Candida albicans from blood culture isolates.

Authors:  D L Brawner; G L Anderson; K Y Yuen
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

7.  Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR.

Authors:  Mahnaz Mahmoudi Rad; Ameneh Sh Zafarghandi; Maryam Amel Zabihi; Mahkam Tavallaee; Yasaman Mirdamadi
Journal:  Infect Dis Obstet Gynecol       Date:  2012-06-26

Review 8.  Association of genotypes with infection types and antifungal susceptibilities in Candida albicans as revealed by recent molecular typing strategies.

Authors:  Feng-Yan Bai
Journal:  Mycology       Date:  2014-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.